Table 4.
c-Jun | JunD | JunB | c-Fos | L-Plastin | |
---|---|---|---|---|---|
Case | |||||
SMZL 26 | + | ++ | −/+ | −/+ | + |
SMZL 27 | + | +/++ | −/+ | −/+ | ++ |
MZL 1 | +/++ | −/+ | −/+ | −/+ | +/++ |
MZL 2 | + | + | −/+ | −/+ | ++ |
MCL 1 | −/+ | −/+ | − | − | + |
MCL 2 | + | + | −/+ | − | + |
B-CLL 1 | + | + | −/+ | − | + |
B-CLL 2 | + | + | −/+ | −/+ | −/+ |
B-CLL 3 | var −/+/++ | ++ | −/+ | −/+ | −/+ |
FL 1 | var−/+/++ | var −/+ | var−/+/++ | − | ++ |
FL 2 | var−/+/++ | var −/+ | var−/+/++ | − | −/+ |
FL 3 | var−/+/++ | var −/+ | var−/+ | − | + |
−, no expression; +, clear expression; ++, strong expression; var, pronounced variable expression levels of the cells.
SMZL, splenic marginal zone lymphoma; MZL, marginal zone lymphoma; MCL, mantle cell lymphoma; FL, follicular lymphoma; B-CLL, B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.